EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Disulfidptosis-Related Genes as Novel Biomarkers and Therapeutic Targets in Dilated Cardiomyopathy

Xiaohong Bo, Jili Fan, Shuai Xu, Yiyao Zeng, Anchen Xu iD, Xiangyu Wang, Hongju Wang, Pinfang Kang, Yangjun Fu, Huimin Fan iD, Xin Tan, Yafeng Zhou iD

Journal of Inflammation Research · 2025-07 · Volume 18 · 9967-9988

DOI: 10.2147/jir.s525114 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Inflammation Research, 2025-07. Verfasst von Xiaohong Bo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Disease, Taihe County People's Hospital, Fuyang, 236600, People's Republic of China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Dilated cardiomyopathy (DCM) is a severe cardiac condition characterized by ventricular dilation and impaired systolic function, leading to heart failure and sudden death. Current treatments have limited efficacy in reversing disease progression. Recent research suggests that disulfidptosis, a novel cell death mechanism, may play a role in DCM pathogenesis, though its specific involvement remains unclear.

Methods

This study utilized multiple GEO datasets to analyze the expression of 24 disulfidptosis-related genes (DiGs) in DCM patients and healthy controls. Differential expression analysis and consensus clustering were used to classify DCM patients into subgroups based on DiGs expression profiles. A predictive model was constructed using four machine learning methods, and its performance was validated with independent datasets. A ceRNA regulatory network was established, and in vivo experiments were conducted using a DCM mouse model to validate key findings.

Results

Nineteen DiGs were differentially expressed between DCM and controls. Consensus clustering divided DCM patients into two subtypes with distinct immune profiles. The support vector machine (SVM) model demonstrated superior diagnostic performance (AUC = 0.983), identifying ACTN4, MYH10, TLN1, DSTN, and NCKAP1 as core predictors. In vivo validation confirmed their expression changes in myocardial tissue. Single-cell RNA-seq further revealed increased fibroblast and macrophage infiltration in DCM, along with enrichment of fibrotic and immune pathways. Quercetin and resveratrol were predicted as potential drugs targeting these core genes.

Conclusion

This study demonstrates that ACTN4, MYH10, TLN1, DSTN, and NCKAP1 play significant roles in the pathogenesis of DCM, influencing immune cell infiltration and metabolic homeostasis. Quercetin and resveratrol were identified as potential therapeutic agents, offering new directions for DCM treatment.

Schlagwörter

Stichwörter der Autor:innen

diagnostic modeldilated cardiomyopathydisulfidptosis-related genesimmune cell infiltration

Autor:innen und Institutionen

  • Department of Cardiovascular Disease, Taihe County People's Hospital, Fuyang, 236600, People's Republic of China.
  • Department of Cardiovascular Disease, Taihe Hospital of Wannan Medical College, Fuyang, 236600, People's Republic of China.
  • Department of Cardiology, The Fourth Affiliated Hospital of Soochow University, Suzhou Dushu Lake Hospital, Medical Center of Soochow University, Suzhou, 215000, People's Republic of China.
  • Institute for Hypertension, Soochow University, Suzhou, 215000, People's Republic of China.
  • Department of Cardiovascular Disease, the First Affiliated Hospital of Bengbu Medical University, Bengbu, 233000, People's Republic of China.
  • Department of Neurology, The Third People's Hospital of Hefei, Hefei City, Anhui Province, 230041, People's Republic of China.

ORCID-Profile: Anchen Xu, Huimin Fan, Yafeng Zhou

Zitieren

APA

Bo, X., Fan, J., Xu, S., Zeng, Y., Xu, A., Wang, X., Wang, H., Kang, P., Fu, Y., Fan, H., Tan, X., & Zhou, Y. (2025). Disulfidptosis-Related Genes as Novel Biomarkers and Therapeutic Targets in Dilated Cardiomyopathy. Journal of Inflammation Research, Volume 18, 9967-9988. https://doi.org/10.2147/jir.s525114

Vancouver

Bo X, Fan J, Xu S, Zeng Y, Xu A, Wang X, et al. Disulfidptosis-Related Genes as Novel Biomarkers and Therapeutic Targets in Dilated Cardiomyopathy. Journal of Inflammation Research. 2025;Volume 18:9967-9988. doi:10.2147/jir.s525114

BibTeX
@article{Bo2025,
  author = {Bo, Xiaohong and Fan, Jili and Xu, Shuai and Zeng, Yiyao and Xu, Anchen and Wang, Xiangyu and Wang, Hongju and Kang, Pinfang and Fu, Yangjun and Fan, Huimin and Tan, Xin and Zhou, Yafeng},
  title = {Disulfidptosis-Related Genes as Novel Biomarkers and Therapeutic Targets in Dilated Cardiomyopathy},
  journal = {Journal of Inflammation Research},
  year = {2025},
  volume = {Volume 18},
  pages = {9967--9988},
  doi = {10.2147/jir.s525114}
}
Kostenlos starten →